Mesirow Financial Investment Management, Inc. Astrazeneca PLC Transaction History
Mesirow Financial Investment Management, Inc.
- $4.9 Billion
- Q1 2025
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 11,033 shares of AZN stock, worth $793,603. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,033
Previous 11,414
3.34%
Holding current value
$793,603
Previous $747,000
8.43%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,429Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.11 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.92 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.56 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.29 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.25 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...